Skip to main content
. 2021 Dec 16;32(23-24):1433–1438. doi: 10.1089/hum.2021.124

Figure 1.

Figure 1.

Summary of genetic modification approaches for AAV capsids. Generation of highly diverse mutants from either error-prone PCR, peptide display library, or DNA shuffling among different capsid serotypes offer in vivo selection screenings. Enhanced AAV transduction and/or evasion of neutralizing antibodies can be achieved through these approaches. AAV, adeno-associated virus.